The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Association of COMT and TPMT with treatment failure (TF), neuropathy (NTOX), and ototoxicity (OTOX) in patients with testicular cancer (TC) after cisplatin-based chemotherapy (CBCT).
C. Fung
No relevant relationships to disclose
D. J. Vaughn
No relevant relationships to disclose
N. Mitra
No relevant relationships to disclose
S. Vardhanabhuti
No relevant relationships to disclose
S. L. Ciosek
No relevant relationships to disclose
K. L. Nathanson
No relevant relationships to disclose
P. A. Kanetsky
No relevant relationships to disclose